Back

Activation of ASIC3 attenuates thrombogenesis: a self-protective mechanism of the body

29 August 2026 (13:15 - 13:25)
Organised by: Logo
Congress Presentation Part of: Decoding plaque vulnerability: inflammation, lipoproteins, and intracoronary imaging insights Thrombosis, Platelets, and Coagulation ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Peng Zhang

The Ninth People's Hospital, Shanghai (China)

5 More presentations in this session

Presentation thumbnail
Macrophage FOXK2 promotes cardiac repair in myocardial infarction with stress hyperglycemia
Doctor J. Jin (Beijing, CN)
Abstract Slides
Presentation thumbnail
The non-Lp(a) ApoB-to-Lp(a) ratio as an integrative biomarker of coronary plaque burden and vulnerability: insights from PROSPECT II
Professor S. Tsimikas (La Jolla, US)
Abstract Slides
Presentation thumbnail
Comparative impact of local and systemic inflammation on vessel-oriented outcomes following PCI in coronary artery disease
Mr Z. Ye (Beijing, CN)
Abstract Slides
Presentation thumbnail
Serial OCT-based coronary physiology and plaque composition in vessels with nonobstructive coronary lesions following intensive lipid-lowering therapy: YELLOW III sub-study
Doctor P. C Revaiah (New York, US)
Abstract Slides
Presentation thumbnail
Does lipoprotein(a) associate with coronary high-risk plaque in patients without hypercholesterolemia? Insights from optical coherence tomography imaging
Doctor C. Fang (Harbin, CN)
Abstract Slides

Access the full session

Session thumbnail
Decoding plaque vulnerability: inflammation, lipoproteins, and intracoronary imaging insights
Video

The Event

Event poster

ESC Congress 2026

29 August 2026 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Platelet-specific deletion of acetyl-CoA carboxylase 1 decreases phospholipid content and impairs platelet functions
27 August 2021
thumbnail
Congress Presentation
Role of Genetic Polymorphisms of ion channels in the pathophysiology of coronary microvascular dysfunction and ischemic heart disease: an update
31 August 2019
thumbnail
Congress Presentation
Efficacy and safety of cangrelor on top of anticoagulation in patients with myocardial infarction related cardiogenic shock or cardiac arrest receiving va ecmo: preliminary data from a phase 2 trial
20 February 2026
thumbnail
Congress Presentation
Residual platelet activity and systemic inflammation in patients with chronic coronary syndrome in the context of aspirin monotherapy.
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources